| NCT04137289 |
A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT04137289 |
Recruiting |
Boehringer Ingelheim |
2023-04-04 |
| NCT03337087 |
Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer |
https://ClinicalTrials.gov/show/NCT03337087 |
Recruiting |
Academic and Community Cancer Research United |
2020-11-07 |
| NCT03329690 |
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] |
https://ClinicalTrials.gov/show/NCT03329690 |
Active, not recruiting |
Daiichi Sankyo, Inc. |
2020-09-30 |
| NCT03321396 |
Hydrogel Injection to Assist Endoscopic Submucosal Dissection |
https://ClinicalTrials.gov/show/NCT03321396 |
Completed |
National Cheng-Kung University Hospital |
2018-08-20 |
| NCT03309917 |
The Effect of Blood Pressure on Cerebral Blood Flow During Propofol Anesthesia |
https://ClinicalTrials.gov/show/NCT03309917 |
Completed |
Rigshospitalet, Denmark |
2018-04-19 |
| NCT03306693 |
Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers |
https://ClinicalTrials.gov/show/NCT03306693 |
Recruiting |
University Hospital, Lille |
2019-10-31 |
| NCT03271255 |
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) |
https://ClinicalTrials.gov/show/NCT03271255 |
Recruiting |
Shenzhen People’s Hospital |
2022-09-30 |
| NCT03267524 |
Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers |
https://ClinicalTrials.gov/show/NCT03267524 |
Active, not recruiting |
City of Hope Medical Center |
2020-11-30 |
| NCT03221335 |
EUS-guided RFA for Solid Abdominal Neoplasms |
https://ClinicalTrials.gov/show/NCT03221335 |
Recruiting |
Chinese University of Hong Kong |
2021-04-30 |
| NCT03172403 |
Skeletal Muscle Expression of Myostatin and Cancer of Digestive System Associated Cachexia |
https://ClinicalTrials.gov/show/NCT03172403 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2020-08-01 |
| NCT03117348 |
Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients |
https://ClinicalTrials.gov/show/NCT03117348 |
Completed |
Jinling Hospital, China |
2018-12-24 |
| NCT03115957 |
Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients |
https://ClinicalTrials.gov/show/NCT03115957 |
Completed |
Jinling Hospital, China |
2018-12-30 |
| NCT03072472 |
BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities |
https://ClinicalTrials.gov/show/NCT03072472 |
Completed |
South Tyneside and Sunderland NHS Foundation Trust |
2018-02-13 |
| NCT02897778 |
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02897778 |
Completed |
Syndax Pharmaceuticals |
2017-03-31 |
| NCT02859064 |
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres |
https://ClinicalTrials.gov/show/NCT02859064 |
Active, not recruiting |
SCRI Development Innovations, LLC |
2020-04-30 |
| NCT02795988 |
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer |
https://ClinicalTrials.gov/show/NCT02795988 |
Recruiting |
Imugene Limited |
2020-12-31 |
| NCT02785783 |
Endoringsâ„¢ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection |
https://ClinicalTrials.gov/show/NCT02785783 |
Completed |
Portsmouth Hospitals NHS Trust |
2018-08-07 |
| NCT02784652 |
Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT02784652 |
Completed |
Severance Hospital |
2017-02-28 |
| NCT02744651 |
EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract |
https://ClinicalTrials.gov/show/NCT02744651 |
Recruiting |
Region Skane |
2020-09-30 |
| NCT02713269 |
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord |
https://ClinicalTrials.gov/show/NCT02713269 |
Recruiting |
M.D. Anderson Cancer Center |
2022-07-01 |
| NCT02575898 |
Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study |
https://ClinicalTrials.gov/show/NCT02575898 |
Completed |
Dartmouth-Hitchcock Medical Center |
2018-07-12 |
| NCT02631590 |
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02631590 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2019-11-23 |
| NCT02507414 |
Mesenteric Traction Syndrome During Upper Gastrointestinal Surgery |
https://ClinicalTrials.gov/show/NCT02507414 |
Completed |
Rigshospitalet, Denmark |
2016-09-30 |
| NCT02485561 |
Evaluating Strategies to Present Colon Cancer Screening Information |
https://ClinicalTrials.gov/show/NCT02485561 |
Completed |
Washington University School of Medicine |
2017-01-31 |
| NCT02450656 |
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02450656 |
Recruiting |
The Netherlands Cancer Institute |
2019-05-31 |
| NCT02444572 |
Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® |
https://ClinicalTrials.gov/show/NCT02444572 |
Recruiting |
Les Laboratoires des Médicaments Stériles |
2020-12-31 |
| NCT02356471 |
Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery |
https://ClinicalTrials.gov/show/NCT02356471 |
Completed |
Wake Forest University Health Sciences |
2016-10-31 |
| NCT02333188 |
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02333188 |
Completed |
University of Chicago |
2017-12-31 |
| NCT02319018 |
Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT02319018 |
Completed |
National Cancer Institute (NCI) |
2018-09-29 |
| NCT02312167 |
Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) |
https://ClinicalTrials.gov/show/NCT02312167 |
Completed |
Institut Mutualiste Montsouris |
2015-10-31 |
| NCT02221700 |
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies |
https://ClinicalTrials.gov/show/NCT02221700 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-04-30 |
| NCT02192333 |
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02192333 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2017-10-07 |
| NCT01291407 |
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer |
https://ClinicalTrials.gov/show/NCT01291407 |
Completed |
Chinese Academy of Medical Sciences |
2013-08-31 |
| NCT02056015 |
A Phase I Study of MLN6907 in Patients With Metastatic Colorectal |
https://ClinicalTrials.gov/show/NCT02056015 |
Completed |
Takeda |
2015-09-30 |
| NCT01996306 |
A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC |
https://ClinicalTrials.gov/show/NCT01996306 |
Completed |
Epidemiological and Clinical Research Information Network |
2017-11-20 |
| NCT01982994 |
Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients |
https://ClinicalTrials.gov/show/NCT01982994 |
Completed |
Milton S. Hershey Medical Center |
2015-07-31 |
| NCT01964430 |
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the “Apact” Study) |
https://ClinicalTrials.gov/show/NCT01964430 |
Active, not recruiting |
Celgene |
2018-12-31 |
| NCT01946854 |
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei |
https://ClinicalTrials.gov/show/NCT01946854 |
Recruiting |
M.D. Anderson Cancer Center |
2021-07-31 |
| NCT01916447 |
A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors. |
https://ClinicalTrials.gov/show/NCT01916447 |
Completed |
Taiho Oncology, Inc. |
2017-09-30 |
| NCT01832116 |
89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients |
https://ClinicalTrials.gov/show/NCT01832116 |
Completed |
University Medical Center Groningen |
2014-05-31 |
| NCT01790035 |
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT01790035 |
Active, not recruiting |
Washington University School of Medicine |
2017-01-12 |
| NCT01693445 |
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT01693445 |
Completed |
Hallym University Medical Center |
2014-02-28 |
| NCT01640665 |
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT01640665 |
Completed |
Yale University |
2014-08-31 |
| NCT01639911 |
Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT01639911 |
Completed |
University of Illinois at Chicago |
2016-07-28 |
| NCT01625351 |
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas |
https://ClinicalTrials.gov/show/NCT01625351 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2020-09-18 |
| NCT01567488 |
Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET |
https://ClinicalTrials.gov/show/NCT01567488 |
Completed |
Grupo Espanol de Tumores Neuroendocrinos |
2014-09-01 |
| NCT01552291 |
The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies |
https://ClinicalTrials.gov/show/NCT01552291 |
Completed |
University Hospital Inselspital, Berne |
2018-02-10 |
| NCT01476592 |
A Biological Study of Resveratrol’s Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT01476592 |
Completed |
University of Wisconsin, Madison |
2013-10-31 |
| NCT01434069 |
Phase I Trial of Combination of FOLFIRI and SOM 230 |
https://ClinicalTrials.gov/show/NCT01434069 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2015-12-31 |
| NCT04426669 |
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering |
https://ClinicalTrials.gov/show/NCT04426669 |
Recruiting |
Intima Bioscience, Inc. |
2022-10-31 |
| NCT04393584 |
FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT04393584 |
Recruiting |
Blokhin’s Russian Cancer Research Center |
2024-01-01 |
| NCT04207463 |
A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT04207463 |
Recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2020-12-31 |
| NCT04197310 |
Cabozantinib and Nivolumab for Carcinoid Tumors |
https://ClinicalTrials.gov/show/NCT04197310 |
Recruiting |
Dana-Farber Cancer Institute |
2021-12-26 |
| NCT04171141 |
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. |
https://ClinicalTrials.gov/show/NCT04171141 |
Recruiting |
Pfizer |
2023-06-14 |
| NCT04145297 |
Ulixertinib (BVD-523) and Hydroxychloroquine in Patients w Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas |
https://ClinicalTrials.gov/show/NCT04145297 |
Recruiting |
University of Utah |
2023-01-30 |
| NCT04084249 |
Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer - Intervention Trial 2 |
https://ClinicalTrials.gov/show/NCT04084249 |
Recruiting |
University of Aarhus |
2022-12-01 |
| NCT04080843 |
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients |
https://ClinicalTrials.gov/show/NCT04080843 |
Recruiting |
Zhejiang University |
2020-08-31 |
| NCT04010227 |
Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers |
https://ClinicalTrials.gov/show/NCT04010227 |
Recruiting |
Indiana University |
2021-05-31 |
| NCT03978078 |
A Clinicobiological Database in Metastatic Digestive Cancers |
https://ClinicalTrials.gov/show/NCT03978078 |
Recruiting |
Institut du Cancer de Montpellier - Val d’Aurelle |
2021-04-30 |
| NCT03800693 |
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT03800693 |
Recruiting |
Emory University |
2021-03-31 |
| NCT03724071 |
Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. |
https://ClinicalTrials.gov/show/NCT03724071 |
Recruiting |
Transgene |
2020-12-31 |
| NCT03717298 |
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT03717298 |
Recruiting |
Catalysis SL |
2020-10-30 |
| NCT03602677 |
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage |
https://ClinicalTrials.gov/show/NCT03602677 |
Recruiting |
Oulu University Hospital |
2020-09-01 |
| NCT03597581 |
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT03597581 |
Recruiting |
Rgenix, Inc. |
2020-07-31 |
| NCT03559543 |
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT03559543 |
Recruiting |
Catalysis SL |
2020-11-30 |
| NCT03549494 |
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction |
https://ClinicalTrials.gov/show/NCT03549494 |
Recruiting |
Catalysis SL |
2020-11-01 |
| NCT03535727 |
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT03535727 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2021-06-30 |
| NCT03507998 |
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT03507998 |
Recruiting |
Curegenix Inc. |
2020-04-01 |
| NCT03449030 |
A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) |
https://ClinicalTrials.gov/show/NCT03449030 |
Completed |
Takeda |
2020-02-27 |
| NCT03411915 |
A Study of XmAb®18087 in Subjects With NET and GIST |
https://ClinicalTrials.gov/show/NCT03411915 |
Recruiting |
Xencor, Inc. |
2021-03-31 |
| NCT01129310 |
First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. |
https://ClinicalTrials.gov/show/NCT01129310 |
Completed |
AHS Cancer Control Alberta |
2018-05-18 |
| NCT01037049 |
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks |
https://ClinicalTrials.gov/show/NCT01037049 |
Active, not recruiting |
Royal Marsden NHS Foundation Trust |
2014-12-08 |
| NCT00990535 |
High Dose Somatostatin Analogues in Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT00990535 |
Completed |
Federico II University |
2007-12-31 |
| NCT01927965 |
Study of Minnelideâ„¢ in Patients With Advanced GI Tumors |
https://ClinicalTrials.gov/show/NCT01927965 |
Completed |
Minneamrita Therapeutics LLC |
2016-10-31 |
| NCT03037385 |
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03037385 |
Recruiting |
Blueprint Medicines Corporation |
2021-12-31 |
| NCT02837679 |
Oncogeriatric Intervention and Follow-up at Home |
https://ClinicalTrials.gov/show/NCT02837679 |
Active, not recruiting |
University of Aarhus |
2019-09-30 |
| NCT02148159 |
Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer |
https://ClinicalTrials.gov/show/NCT02148159 |
Completed |
University of Florida |
2016-05-31 |
| NCT04447443 |
Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT04447443 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2021-06-30 |
| NCT00793871 |
Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor |
https://ClinicalTrials.gov/show/NCT00793871 |
Completed |
Pfizer |
2014-04-30 |
| NCT00725712 |
Study of GSK1363089 in Metastatic Gastric Cancer |
https://ClinicalTrials.gov/show/NCT00725712 |
Completed |
GlaxoSmithKline |
2009-11-01 |
| NCT00680901 |
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib |
https://ClinicalTrials.gov/show/NCT00680901 |
Active, not recruiting |
Novartis |
2012-09-24 |
| NCT00570635 |
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib |
https://ClinicalTrials.gov/show/NCT00570635 |
Completed |
Exelixis |
2009-05-31 |
| NCT00526669 |
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib |
https://ClinicalTrials.gov/show/NCT00526669 |
Completed |
GlaxoSmithKline |
2011-04-30 |
| NCT00486954 |
Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer |
https://ClinicalTrials.gov/show/NCT00486954 |
Completed |
GlaxoSmithKline |
2012-01-31 |
| NCT00465725 |
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00465725 |
Completed |
Poniard Pharmaceuticals |
2009-07-31 |
| NCT00436657 |
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT00436657 |
Completed |
M.D. Anderson Cancer Center |
2011-04-30 |
| NCT00422409 |
Endoscopic Stenting of Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00422409 |
Completed |
Oslo University Hospital |
2009-04-30 |
| NCT00392366 |
Laser Interstitial Thermal Therapy Under “Real Time” MRI Guidance for “Minimal Invasive” Treatment of Liver Metastasis |
https://ClinicalTrials.gov/show/NCT00392366 |
Completed |
BioTex, Inc. |
NA |
| NCT00390182 |
Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) |
https://ClinicalTrials.gov/show/NCT00390182 |
Completed |
University of Maryland, Baltimore |
2011-05-31 |
| NCT00289445 |
Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) |
https://ClinicalTrials.gov/show/NCT00289445 |
Completed |
University Hospital Tuebingen |
2006-03-31 |
| NCT00247338 |
The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients |
https://ClinicalTrials.gov/show/NCT00247338 |
Completed |
Sino-Swed Pharmaceutical Corporation |
2006-04-30 |
| NCT00220168 |
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours |
https://ClinicalTrials.gov/show/NCT00220168 |
Completed |
Royal Marsden NHS Foundation Trust |
NA |
| NCT00220064 |
A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours |
https://ClinicalTrials.gov/show/NCT00220064 |
Completed |
Royal Marsden NHS Foundation Trust |
NA |
| NCT00196885 |
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training |
https://ClinicalTrials.gov/show/NCT00196885 |
Completed |
German Cancer Research Center |
NA |
| NCT00190801 |
Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma |
https://ClinicalTrials.gov/show/NCT00190801 |
Completed |
Eli Lilly and Company |
NA |
| NCT00120939 |
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00120939 |
Completed |
Pharmacyclics LLC. |
NA |
| NCT00826410 |
Prospective Study on the Value of Subcutaneous Drains in Gastrointestinal Surgery |
https://ClinicalTrials.gov/show/NCT00826410 |
Completed |
University Hospital Freiburg |
2004-12-31 |
| NCT00052962 |
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis |
https://ClinicalTrials.gov/show/NCT00052962 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-09-30 |
| NCT00001431 |
A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas |
https://ClinicalTrials.gov/show/NCT00001431 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00041808 |
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver |
https://ClinicalTrials.gov/show/NCT00041808 |
Completed |
FeRx |
NA |